RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $6.0M of Rhythm Pharmaceuticals, Inc.
10% owner
Bought$6,035,000
$17.00Price
355,000Shares
+14%Stake
What RYTM did for a copier
Prices for RYTM after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Oct 10. Filed Tue, Oct 10, 4:21 PM ET, after the close. Not investment advice.